Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: fibromyalgia

Fibromyalgia & Bipolar Spectrum Disorder: A Shared Pathophysiology May Lead to Better Drug Targets

Lara C. Pullen, PhD  |  March 21, 2016

Patients suffering from fibromyalgia and those suffering from bipolar spectrum disorder experience similar symptoms. Research suggests that these diseases may share a pathophysiological process, particularly a similar impairment in the prefrontal-limbic networks of the brain. A new editorial addresses how a better understanding of the potential shared biological underpinning of these diseases could result in unique drug targets…

Filed under:ConditionsPain SyndromesSoft Tissue Pain Tagged with:Bipolar Spectrum DisorderFibromyalgiaMental HealthPain

FDA Update: Infliximab Biosimilar Garners Support & Fibromyalgia Drug Receives Fast Track

Michele B. Kaufman, PharmD, BCGP  |  February 17, 2016

Recently, an FDA committee announced support for the approval of CT-P13, an infliximab biosimilar. The FDA has also fast tracked the development of a fibromyalgia treatment designed for multiple symptoms…

Filed under:Biologics/DMARDsConditionsDrug UpdatesPain Syndromes Tagged with:drug developmentFDAFibromyalgiaFood and Drug Administrationinfliximab

Exercise Guidelines for Fibromyalgia Patients

Marie B. Corkery, PT, DPT, MHS, & Lauren Tarsi, DPT  |  October 14, 2015

Fibromyalgia syndrome (FMS) is a condition characterized by widespread pain, abnormal pain processing, sleep disturbance and fatigue. It is commonly associated with psychological distress and co-morbid conditions. Impaired cognition is common in individuals with FMS, and is often referred to as fibrofog.1 According to the U.S. Centers for Disease Control and Prevention, the prevalence of…

Filed under:ConditionsPain SyndromesSoft Tissue Pain Tagged with:ClinicalExerciseFibromyalgiaFMSpatient carePhysical TherapyTreatment

Intensive Program Relieves Symptoms of Juvenile Fibromyalgia

Lara C. Pullen, PhD  |  August 17, 2015

Pain can be reduced and functionality significantly improved for children with fibromyalgia without drug therapy, according to a study of 64 children in Philadelphia. Researchers combined intensive physical therapy and psychotherapy in individualized programs to treat the fibromyalgia patients…

Filed under:ConditionsPain SyndromesSoft Tissue Pain Tagged with:FibromyalgiaPainPain Management

Rheumatology Coding Corner Question: Trigger-Point Injections for Fibromyalgia

From the College  |  June 15, 2015

A 65-year-old established female patient returns to the office for a follow-up visit for her diagnosis of fibromyalgia. She complains of pain, stiffness and swelling in her left hand, elbow and neck that is persistent since her last visit. The pain is considerably worse in the morning. She denies any fevers, cough or dyspnea. The…

Filed under:Billing/CodingConditionsFrom the CollegePain SyndromesPractice SupportSoft Tissue Pain Tagged with:BillingCodingFibromyalgiapatient carerheumatologisttrigger-point injection

Rheumatology Coding Corner Answer: Trigger Point Injections for Fibromyalgia

From the College  |  June 15, 2015

Take the challenge. CPT codes: 99213-25, 20553, 73120/LT Diagnosis: ICD-9 7291 ICD-10 M79.7 Coding for trigger-point injections continues to create a lot of confusion on proper coding guidelines. Keep in mind, two CPT4 codes can be used for trigger-point procedures: 20552—Injection(s); single or multiple trigger point(s), one or two muscle(s); and 20553—Single or multiple trigger…

Filed under:Billing/CodingConditionsFrom the CollegePain SyndromesPractice Support Tagged with:BillingCodingFibromyalgiapatient carerheumatologisttrigger-point injection

Restoration of Sleep Physiology vs. Sedation for Sleep Disorders, Fibromyalgia

Bruce Rothschild, MD  |  June 15, 2015

Sleep disturbance is an important medical problem, requiring intervention, not simply to reduce latency to its onset, but to ensure achievement of the depth of sleep that has been documented to restore homeostasis and prevent the falls that are responsible for so much morbidity and mortality.1 Sleep disturbance is present in 50% of people over…

Filed under:ConditionsPain SyndromesSoft Tissue Pain Tagged with:DrugsFibromyalgiapatient caresleep disorderTreatment

Progress Made in Search for a Fibromyalgia Biomarker

Lara C. Pullen, PhD  |  May 15, 2015

Fibromyalgia syndrome (FMS), rheumatoid arthritis (RA) and spondyloarthritis (SpA) all exhibit multifaceted manifestations, and many patients exhibit overlapping comorbidities. However, patients with FMS are distinct from others in that they experience widespread pain, fatigue and mood changes, including anxiety and depression. Although its hallmark symptom of pain causes rheumatologists to consider FMS a pain disorder,…

Filed under:ConditionsPain SyndromesResearch RheumSoft Tissue Pain Tagged with:BiomarkersFibromyalgiaResearchT cell

Hypersensitivity to Non-Painful Events May Be Part of Pathology in Fibromyalgia

Staff  |  September 16, 2014

New research shows that patients with fibromyalgia have hypersensitivity to non-painful events based on images of the patients’ brains, which show reduced activation in primary sensory regions and increased activation in sensory integration areas.

Filed under:ConditionsPain SyndromesResearch RheumSoft Tissue Pain Tagged with:Fibromyalgia

Fibromyalgia Pain Associated with Changes in Brain Connectivity

Lara C. Pullen, PhD  |  July 25, 2014

Research suggests weakened sensory cortex connectivity extending beyond the traditional somatosensory domain may contribute to pain associated with fibromyalgia

Filed under:ConditionsPain SyndromesResearch RheumSoft Tissue Pain Tagged with:brainFibromyalgiaPain

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 32
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences